van Loon A M, van der Logt J T, Heessen F W, van der Veen J
J Clin Microbiol. 1985 Apr;21(4):558-61. doi: 10.1128/jcm.21.4.558-561.1985.
An antibody capture enzyme-linked immunosorbent assay was developed for detection of immunoglobulin E antibody to cytomegalovirus (CMV-IgE). Affinity-purified anti-human IgE-coated microtiter plates were used to separate IgE from other classes of antibody in serum. Virus-specific IgE was detected by subsequent incubation with horseradish peroxidase-labeled CMV antigen and substrate. The assay was shown to be very sensitive, since in most positive sera CMV-IgE was still detected at a dilution of 1:5,000. Of 45 patients with primary CMV infection, 43 (96%) were found to produce CMV-IgE. In contrast, CMV-IgE was detected in only 4 (9%) of 44 patients with recurrent CMV infection and in 1 of 144 healthy controls. Furthermore, the level of CMV-IgE in patients with recurrent CMV infection appeared to be lower than that in patients with primary infection. Preliminary examination of successive sera suggested that CMV-IgE is produced somewhat slower than CMV-IgM and -IgA but persists for a shorter period. These results suggest that CMV-IgE may be used as an indicator of primary CMV infection.
开发了一种抗体捕获酶联免疫吸附测定法,用于检测抗巨细胞病毒免疫球蛋白E抗体(CMV-IgE)。用亲和纯化的抗人IgE包被的微量滴定板从血清中的其他抗体类别中分离出IgE。通过随后与辣根过氧化物酶标记的巨细胞病毒抗原和底物孵育来检测病毒特异性IgE。该测定法显示出非常灵敏,因为在大多数阳性血清中,在1:5000的稀释度下仍能检测到CMV-IgE。在45例原发性巨细胞病毒感染患者中,发现43例(96%)产生CMV-IgE。相比之下,在44例复发性巨细胞病毒感染患者中,仅4例(9%)检测到CMV-IgE,在144例健康对照者中仅1例检测到。此外,复发性巨细胞病毒感染患者的CMV-IgE水平似乎低于原发性感染患者。对连续血清的初步检查表明,CMV-IgE的产生比CMV-IgM和-IgA稍慢,但持续时间较短。这些结果表明,CMV-IgE可作为原发性巨细胞病毒感染的指标。